Wealth Architects’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,100
Closed -$25K 194
2022
Q1
$25K Buy
+16,100
New +$25K ﹤0.01% 205
2021
Q3
Sell
-17,500
Closed -$50K 191
2021
Q2
$50K Sell
17,500
-18,500
-51% -$52.9K 0.01% 187
2021
Q1
$85K Buy
36,000
+18,000
+100% +$42.5K 0.02% 164
2020
Q4
$32K Buy
+18,000
New +$32K 0.01% 161